NBO Pharma
Bedford, US · Founded 2021 · Delaware corporation
Founders & leadership
FD
Fredric David PriceExecutive
Board
RF
Robert FriedmanBoard director
BG
Bard GeesamanBoard director
CF
Colin FosterBoard director
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 1 round · 2025
▶$7.6MraisedJan 2026 · 93 investors · PharmaceuticalsRule 506(c)
▶$7.6MraisedJan 2026 · 93 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Colin FosterDirector
- Fredric David PriceExecutive Officer, Director
- Robert FriedmanDirector
- Bard GeesamanDirector
- Offering amount
- $7.6M
- Amount sold
- $7.6M
- Minimum investment
- $10K
- Sales commissions
- $947K
- Placement agents
- Paulson Investment Company, LLC
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has NBO Pharma raised?
- NBO Pharma has disclosed $7.6M raised across 1 round.
- Where is NBO Pharma headquartered?
- NBO Pharma is headquartered in Bedford, US.